Mar 29, 2026Gut MicrobiomeFMT for Viral Diseases: Why the Clinical Evidence Falls ShortFMT cures recurrent C. difficile, but evidence for HIV, HBV, COVID-19, and CMV remains limited to small, confounded pilot studies.fmtc. difficilegut dysbiosishivRead article →
Mar 29, 2026Longevity ResearchHIV, Epigenetic Aging, and Why ART Leaves a Gut GapHIV accelerates epigenetic aging in most studies. ART slows the trend, but gut dysfunction may sustain it—and metformin evidence remains small.hivbiological agingdna methylationepigenetic clocksRead article →
Mar 29, 2026MicrobiomeHIV Gut Dysbiosis and FMT: A Promising but Early SignalART suppresses HIV, yet gut dysbiosis may sustain inflammation. A small placebo-controlled FMT trial shifted diversity, not clinical outcomes.gut dysbiosismicrobiotahivaccelerated agingRead article →